Abstract:
:Immuno-oncology has gained momentum thanks to the success of strategies aimed at enhancing immune-mediated antitumor response. The field of immunotherapeutic transport oncophysics investigates the physical processes that drive cancer immunotherapies. This review discusses three main aspects that determine the outcome of an immunotherapy-based treatment from a physical point of view; (i) space, the distribution of cancer and immune cells within tumor masses, (ii) time, the temporal dynamic of immune response against tumors, and (iii) activity, the ability of immune cell populations to suppress cancer. Upon introducing these topics with examples from the literature, we investigate in detail two cases where the interplay between space, time, and activation variables determines immune response: nanodendritic cell vaccines and immunosuppression in ovarian cancer.
journal_name
Trends Cancerjournal_title
Trends in cancerauthors
Nizzero S,Shen H,Ferrari M,Corradetti Bdoi
10.1016/j.trecan.2019.11.008subject
Has Abstractpub_date
2020-01-01 00:00:00pages
40-48issue
1eissn
2405-8033issn
2405-8025pii
S2405-8033(19)30256-0journal_volume
6pub_type
杂志文章,评审相关文献
Trends in Cancer文献大全abstract::Obesity has been associated with increased severity of diagnoses for several types of cancer, and recent evidence suggests that the mechanism by which obese tissues contribute to cancer progression involves the extracellular matrix (ECM). Understanding the physicochemical differences between lean and obese ECM, and ho...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2018.02.001
更新日期:2018-04-01 00:00:00
abstract::Dynamic changes in the colorectal cancer (CRC) signalome and tumor genetic heterogeneity underlie acquired drug resistance. Improving treatment-related decisions is facilitated by an emerging consensus in the classification of tumor subtypes as well as by real-time monitoring of predictive biomarkers in circulating tu...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2017.01.003
更新日期:2017-03-01 00:00:00
abstract::Fusobacterium nucleatum is an oral bacterium associated with colorectal cancer (CRC) proliferation, chemoresistance, inflammation, metastasis, and now DNA damage. While controlling F. nucleatum through antibiotics could reduce cancer severity, this article proposes additional strategies to block Fusobacterium-host int...
journal_title:Trends in cancer
pub_type: 杂志文章
doi:10.1016/j.trecan.2020.11.006
更新日期:2020-12-09 00:00:00
abstract::The 'mild' cold stress caused by standard sub-thermoneutral housing temperatures used for laboratory mice in research institutes is sufficient to significantly bias conclusions drawn from murine models of several human diseases. We review the data leading to this conclusion, discuss the implications for research and s...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2016.03.005
更新日期:2016-04-01 00:00:00
abstract::Dendritic cells (DCs) are key orchestrators of immune responses. A specific DC subset, conventional type 1 DCs (cDC1s), has been recently associated with human cancer patient survival and, in preclinical models, is critical for the spontaneous rejection of immunogenic cancers and for the success of T cell-based immuno...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2018.09.001
更新日期:2018-11-01 00:00:00
abstract::The rapidly evolving field of cancer immunotherapy recently saw the approval of several new therapeutic antibodies. Several cell therapies, for example, chimeric antigen receptor-expressing T cells (CAR-T), are currently in clinical trials for a variety of cancers and other diseases. However, approaches to monitor cha...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2018.03.009
更新日期:2018-05-01 00:00:00
abstract::Precision medicine requires appropriate application of genomics in clinical practice. In cancer, we have witnessed practice-changing examples of how genomic knowledge is translated into more tailored and effective therapies. The next opportunity is to embed cancer genomics in clinical context so that patient-centric l...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2015.07.010
更新日期:2015-09-01 00:00:00
abstract::The regulation of immune responses by tumors is central to their survival. By diminishing the production of interferon (IFN) and other inflammatory mediators, tumors enhance immune evasion. Responses initiated by nucleic acid sensors and triggered by dysregulated RNA transcription and cytoplasmic DNA undergo down-modu...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2019.03.004
更新日期:2019-05-01 00:00:00
abstract::Lysophosphatidate (LPA) is emerging as a potent mediator of cancer progression in the tumor microenvironment. Strategies for targeting LPA signaling have recently entered clinical trials for fibrosis. These therapies have potential to improve the efficacies of existing chemotherapies and radiotherapy by attenuating ch...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2017.09.004
更新日期:2017-11-01 00:00:00
abstract::Although immunotherapy has proved to be effective in a variety of cancer subtypes, the role of immune checkpoint inhibition in the treatment of prostate cancer remains unclear. Here we review results from the latest clinical trials and discuss data suggesting that certain genetic mutations may confer increased sensiti...
journal_title:Trends in cancer
pub_type: 杂志文章
doi:10.1016/j.trecan.2020.01.003
更新日期:2020-03-01 00:00:00
abstract::Alternative lengthening of telomeres (ALT) is an enigmatic process that allows certain cancers to maintain telomeres in the absence of telomerase. ALT cancers are frequently defective for ATRX/DAXX, a chaperone complex that deposits histone variant H3.3 at telomeres. We propose that mutations in alpha thalassemia-ment...
journal_title:Trends in cancer
pub_type: 杂志文章
doi:10.1016/j.trecan.2016.02.003
更新日期:2016-03-01 00:00:00
abstract::Dicer-deficient cancers have poor prognoses, which is linked to the degradation of tumour-suppressing miRNA precursors by the Translin-Trax (Tn-Tx) ribonuclease. Inhibition of Tn-Tx potentially offers a new therapeutic intervention point. However, Tn-Tx functions in an array of biological processes, and here we consid...
journal_title:Trends in cancer
pub_type: 杂志文章
doi:10.1016/j.trecan.2020.02.014
更新日期:2020-06-01 00:00:00
abstract::GLI-similar 1-3 (GLIS1-3), a subfamily of Krüppel-like zinc finger transcription factors, function as key regulators of several biological processes important to oncogenesis, including control of cell proliferation, differentiation, self-renewal, and epithelial-mesenchymal transition. This review provides a short over...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2019.07.005
更新日期:2019-09-01 00:00:00
abstract::The tumor microenvironment has an essential role in defining tumor malignancy, since it can either promote or prevent tumor initiation and subsequent progression and metastatic dissemination. Recent studies demonstrate that highly aggressive cancer cells display a high degree of metabolic plasticity paralleled by the ...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2016.11.001
更新日期:2016-12-01 00:00:00
abstract::Phosphoinositide 3-kinase (PI3K) generation of PI(3,4,5)P3 from PI(4,5)P2 and the subsequent activation of Akt and its downstream signaling cascades (e.g. mTORC1) dominates the landscape of phosphoinositide signaling axis in cancer research. However, PI(4,5)P2 is breaking its boundary as merely a substrate for PI3K an...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2016.05.009
更新日期:2016-07-01 00:00:00
abstract::For millenia, plants have been a major source of medications against human and animal diseases. In the case of anticancer agents, a significant number of current agents can trace their source back to nominally plant secondary metabolites, with examples being taxol, vinca alkaloids, camptothecin (CPT), and their modifi...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2018.08.002
更新日期:2018-10-01 00:00:00
abstract::Epithelial-to-mesenchymal transition (EMT) determines the most lethal features of cancer, metastasis formation and chemoresistance, and therefore represents an attractive target in oncology. However, direct targeting of EMT effector molecules is, in most cases, pharmacologically challenging. Since emerging research ha...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2020.06.005
更新日期:2020-11-01 00:00:00
abstract::Pancreatic ductal adenocarcinoma (PDAC) represents a major global health problem that causes over 200000 deaths each year worldwide. The disease is highly resistant to cytotoxic and targeted therapies and the average survival is less than 12 months. This situation prompted Alessandro Carugo and Giulio Draetta to devel...
journal_title:Trends in cancer
pub_type: 评论,杂志文章
doi:10.1016/j.trecan.2016.07.002
更新日期:2016-08-01 00:00:00
abstract::Traditionally, the efficacy of novel cancer therapies has been confirmed in patients failing regular treatment before being tested in early disease. Improved understanding of the mechanisms guiding therapeutic efficacy may challenge this dogma, suggesting novel therapies to move into early evaluation based on biologic...
journal_title:Trends in cancer
pub_type: 杂志文章
doi:10.1016/j.trecan.2020.11.010
更新日期:2020-12-22 00:00:00
abstract::Cancer-associated fibroblasts (CAFs) are one of the most significant components in the tumour microenvironment (TME), where they can perform several protumourigenic functions. Several studies have recently reported that CAFs are more heterogenous and plastic than was previously thought. As such, there has been a shift...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2019.09.010
更新日期:2019-11-01 00:00:00
abstract::Lactate dehydrogenase (LDH) accounts for the fermentative component of aerobic glycolysis, a near ubiquitous metabolic alteration in cancer. Recently, Oshima et al. developed a bioavailable LDH inhibitor that decreases tumor growth in mice and functions synergistically with mitochondrial respiration inhibitors. These ...
journal_title:Trends in cancer
pub_type: 杂志文章
doi:10.1016/j.trecan.2020.02.012
更新日期:2020-05-01 00:00:00
abstract::The liver is one of the major metabolic organs in the body, susceptible to injury caused by various factors. In response to injury, sophisticated mechanisms are engaged to repair and regenerate the damaged liver, preventing its failure. When the damage is chronic, regeneration goes awry, impairing liver function and c...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2020.08.005
更新日期:2021-01-01 00:00:00
abstract::The survival rate of reproductive-age patients with cancer is increasing, reflecting the advent of better and more efficient therapies. Cancer survivors seek the resumption of a normal and healthy life, which often includes starting a family. Unfortunately, many cancer treatments increase the risk of premature ovarian...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2016.03.006
更新日期:2016-05-01 00:00:00
abstract::Ibrutinib resistance, as a result of coordinated rewiring of signaling networks and enforced tumor microenvironment (TME)-lymphoma interactions, drives unrestrained proliferation and disease progression. To combat resistance mechanisms, we must identify the compensatory resistance pathways and the central modulators o...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2018.01.004
更新日期:2018-03-01 00:00:00
abstract::Cancer immunotherapy has recently emerged as a forefront strategy to fight cancer. Key players in antitumor responses are CD8+ cytolytic T lymphocytes (CTLs) that can detect tumor cells that carry antigens, in other words, small peptides bound to surface major histocompatibility complex (MHC) class I molecules. The su...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2017.07.007
更新日期:2017-10-01 00:00:00
abstract::Even though we have known for over 250 years that cancers spread to regional lymph nodes (LNs) and distant organs, the fundamental question of which anatomical routes are taken by tumor cells has remained a mystery. Two recently published papers in Science, by Pereira et al. and Brown et al., directly address this imp...
journal_title:Trends in cancer
pub_type: 评论,杂志文章
doi:10.1016/j.trecan.2018.05.007
更新日期:2018-08-01 00:00:00
abstract::Neutrophil extracellular traps (NETs) have emerged as significant contributors to cancer-associated pathologies such as metastasis, thrombosis, and organ dysfunction in preclinical models. We review recent discoveries of the involvement of NETs in human cancers and suggest tumor-induced NET formation as an interesting...
journal_title:Trends in cancer
pub_type: 杂志文章
doi:10.1016/j.trecan.2016.10.012
更新日期:2016-11-01 00:00:00
abstract::The molecular basis for the clinical heterogeneity observed in patients with malignant rhabdoid tumors is unknown. Recently, two reports revealed molecular inter-tumor heterogeneity in teratoid/rhabdoid tumors (ATRTs) and extra-cranial MRTs (ecMRTs) using genomic, transcriptomic and epigenomic profiling. Distinct mole...
journal_title:Trends in cancer
pub_type: 评论,杂志文章
doi:10.1016/j.trecan.2016.04.003
更新日期:2016-05-01 00:00:00
abstract::Curative therapy for cancer patients with advanced-stage disease remains elusive. While rare outlier responses to anticancer therapies exist, barriers limit our understanding of the molecular and genetic basis of such profound, life-altering responses. Here, we describe how phenotype-to-genotype studies are elucidatin...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2017.11.004
更新日期:2018-01-01 00:00:00
abstract::Cancers develop within complex tissue environments consisting of diverse innate and adaptive immune cells, along with stromal cells, vascular networks, and many other cellular and noncellular components. The high heterogeneity within the tumor microenvironment (TME) remains a key obstacle in understanding and treating...
journal_title:Trends in cancer
pub_type: 杂志文章,评审
doi:10.1016/j.trecan.2020.02.022
更新日期:2020-07-01 00:00:00